Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects

  • Rita Silva-Reis
  • , Vera L.M. Silva
  • , Susana M. Cardoso
  • , Izabela Michalak
  • , Mirosława Püsküllüoğlu
  • , Daniela Calina
  • , Javad Sharifi-Rad
  • University of Aveiro
  • Universidade de Trás-os-Montes e Alto Douro
  • Wrocław University of Science and Technology
  • Maria Sklodowska-Curie Institute of Oncology
  • Craiova University of Medicine and Pharmacy

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

7 Citas (Scopus)

Resumen

Moscatilin, a bibenzyl derivative from the Dendrobium genus, has been traditionally used in Chinese medicine. Recent studies suggest its potential as a powerful anticancer agent due to its diverse pharmacological properties.This review aims to consolidate current research on moscatilin’s anticancer mechanisms, structure–activity relationships, and therapeutic potential to assess its viability for clinical use. A literature search was performed in PubMed/MedLine, Scopus, and Web of Science.The search focused on “cancer,” “moscatilin,” “anticancer,” “bioactivity,” “dendrobium,” and “pharmacological properties.” Relevant studies on molecular mechanisms, preclinical and clinical efficacy, and bioavailability were reviewed. Moscatilin exhibits significant anticancer effects in lung, breast, colorectal, and pancreatic cancers. It induces apoptosis via the JNK/SAPK pathway, inhibits cell proliferation, and suppresses metastasis. Structure–activity relationship studies reveal that phenolic groups and a two-carbon bridge are crucial for its efficacy. Additionally, moscatilin shows good bioavailability and a favorable safety profile, with low toxicity to healthy cells. Moscatilin demonstrates considerable potential as an anticancer agent, targeting multiple cancer progression pathways. Further clinical trials are essential to confirm its therapeutic efficacy and safety in humans.

Idioma originalInglés
Número de artículo228
PublicaciónMedical Oncology
Volumen41
N.º9
DOI
EstadoPublicada - sept 2024

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects'. En conjunto forman una huella única.

Citar esto